Abstract

Acute mesenteric ischaemia is a rare but severe disease with high mortality and unspecific clinical presentation. High clinical suspicion, use of computed tomographic angiography in diagnosis and urgency with starting treatment once the diagnosis is clear are of uttermost importance. Endovascular therapy has become a promising alternative in the treatment of acute mesenteric ischaemia and there can be measurable advantages to this approach according to recent studies and analyses. The scientific evidence behind this remains to be confirmed with prospective studies. The choice of treatment is individual and depends on the surgeons’ experience and organisational facilities. However, it should be kept in mind that revascularisation is the prerequisite for optimal healing of bowel anastomosis.
In conclusion, it can be said that the diagnosis of acute mesenteric ischemia is feasible, and in some cases the treatment is beneficial and prognosis is good.